Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis
- 1 February 1989
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 114 (2) , 309-314
- https://doi.org/10.1016/s0022-3476(89)80804-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis.Journal of Clinical Pathology, 1986
- IgG Subclass Composition of Intravenous Immunoglobulin Preparations: Clinical RelevanceClinical Infectious Diseases, 1986
- Altered Antibody Isotype in Cystic Fibrosis. Possible Role in Opsonic DeficiencyPediatric Research, 1986
- Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.Journal of Clinical Investigation, 1984
- Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: A 5-year longitudinal studyThe Journal of Pediatrics, 1984
- Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.Journal of Clinical Investigation, 1981
- INHIBITORY EFFECT OF CYSTIC FIBROSIS SERUM ON PSEUDOMONAS PHAGOCYTOSIS BY RABBIT AND HUMAN ALVEOLAR MACROPHAGESPediatric Research, 1979
- Immune Complexes in Cystic FibrosisBMJ, 1975
- A 5 year clinical evaluation of a therapeutic program for patients with cystic fibrosisThe Journal of Pediatrics, 1964
- [131I]Albumin turnover and loss of protein into the sputum in chronic bronchitisClinica Chimica Acta; International Journal of Clinical Chemistry, 1964